Deferred Tax Assets, Valuation Allowance of ADIAL PHARMACEUTICALS, INC. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ADIAL PHARMACEUTICALS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • ADIAL PHARMACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $16,747,446, a 7.6% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ADIAL PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $16,747,446 +$1,188,089 +7.6% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $15,559,357 +$2,028,318 +15% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $13,531,039 +$1,811,852 +15% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q4 2022 $11,719,187 +$2,027,044 +21% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $9,692,143 +$3,633,952 +60% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $6,058,191 -$8,060,809 -57% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q4 2019 $14,119,000 +$6,735,000 +91% 31 Dec 2019 10-K 22 Mar 2021 2020 FY
Q4 2018 $7,384,000 +$6,980,000 +1728% 31 Dec 2018 10-K 20 Mar 2020 2019 FY
Q4 2017 $404,000 31 Dec 2017 10-K 19 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.